Transversus Abdominis Plan (TAP) Block In Transcatheter Aortic Valve Implantation (TAVI)

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jan 1, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a method called the Transversus Abdominis Plane (TAP) block to help manage pain during a procedure known as Transcatheter Aortic Valve Implantation (TAVI). TAVI is a surgery for patients with a narrowed heart valve, and it can be uncomfortable, which might cause patients to move and create complications. By using an ultrasound-guided TAP block to numb the area, the goal is to keep patients comfortable and stable during the procedure, leading to better outcomes for both patients and doctors.

To participate in this trial, you need to be at least 18 years old and scheduled for an elective TAVI procedure. Some reasons you might not be eligible include being younger than 18, having a serious heart condition, being morbidly obese, or having skin issues in the area where the block will be applied. If you join the study, you can expect to receive the TAP block along with sedation, helping to ensure a smoother and more comfortable experience. The trial is currently recruiting participants, and it aims to evaluate how this method improves satisfaction for both patients and healthcare providers.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • TAVI procedures
• • over 18 years of age
• • INR \< 1,5
• • elective procedures
• • Signing the volunteer consent form
• • Providing optimal images in ultrasound imaging
• Exclusion Criteria:
• • \< 18 yers of age
• • emergency procedures
• • morbidly obese patients (BMI\>35kg/m2)
• • Advanced decompensated heart failure with New york Heart Association (NYHA) stage 4
• • Those who have skin infection, lesion, hematoma in the area to be blocked
• • Cannot be communicated and cannot be given a position
• • Allergic to the prescribed medications
• • Pregnants
• • Those who refused to sign volunteer consent form